£VWRL
Selle fondi eesmärk on jälgida FTSE All-World indeksit, mis hõlmab arenenud ja tärkava turumajandusega riikide aktsiaid kogu maailmas.
Nimi | Osakaal | Turukapitalisatsioon | Hind | Muutus päeva jooksul |
|---|---|---|---|---|
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
ICL Group $ICLMaterjalid | 0% | - | ||
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
Aker ASA Nkr AKERTööstus | 0% | - | ||
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
Fuchs SE €FPEMaterjalid | 0% | - | ||
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
Telix Pharmaceutical $TLXTervis | 0% | - | ||
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
Gecina €GFCReal Estate | 0% | - | ||
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
0% | N/A | N/A | N/A | |
Vienna Insurance Group AG €VIGFinants | 0% | - | ||
0% | N/A | N/A | N/A |